Consolidated Statements of Shareholders' Deficit - USD ($)	Common Stock	Additional Paid-In Capital	Retained Earnings (deficits)	Total
Beginning balance, shares at Dec. 31, 2017	25,046,000
Beginning balance, value at Dec. 31, 2017	$ 25,036	$ 3,258,116	$ (4,644,180)	$ (1,361,028)
Clawback of stock granted, shares	(375,000)
Clawback of stock granted, value	$ (375)	375
Payment of outstanding balance for PPM		80,000		80,000
Stock Based Compensation		1,345,825		1,345,825
Stock grant program vesting, shares	558,833
Stock grant program vesting, value	$ 568	(568)
Warrants		4,525		4,525
Net loss			(3,895,873)	(3,895,873)
Ending balance, shares at Dec. 31, 2018	25,229,833
Ending balance, value at Dec. 31, 2018	$ 25,230	4,688,272	(8,540,053)	(3,826,551)
Stock Based Compensation		1,830,426		1,830,426
Stock Options Issued for loan term revisions, value		37,829		37,829
Stock grants issued for loan term revisions, shares	16,000
Stock grants issued for loan term revisions, value	$ 16	31,284		31,300
Stock grant program vesting, shares	1,360,966
Stock grant program vesting, value	$ 1,360	(1,360)
Warrants		614,041		614,041
Stock issuance related to conversion of convertible debentures, shares	1,102,513
Stock issuance related to conversion of convertible debentures, value	$ 1,103	2,655,934		2,657,037
Stock issuance related to acquisition, shares	500,000
Stock issuance related to acquisition, value	$ 500	999,500		1,000,000
Equity value of exercise price associated with convertible debentures		719,479		719,479
Broker warrants associated with issuance of convertible debentures		278,678		278,678
Net loss			(8,350,573)	(8,350,573)
Ending balance, shares at Dec. 31, 2019	28,209,312
Ending balance, value at Dec. 31, 2019	$ 28,209	$ 11,854,083	$ (16,890,626)	$ (5,008,334)